JamesToddRosenbaumMD
Rheumatology • Burlingame, CASenior Vice-President for Research, Corvus Pharmaceuticals, Burlingame, CA.; Richard Chenoweth Professor Emeritus, Legacy Devers Eye Clinic, Portland, OR.
Dr. Rosenbaum is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
863 Mitten Road
Suite 102
Burlingame, CA 94010Phone+1 503-381-3130- Is this information wrong?
Summary
- I am a board certified rheumatologist with special expertise in ocular inflammatory diseases. I am currently employed full-time as the Senior Vice-President for Research at Corvus Pharmaceuticals.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Allergy and Immunology, 1978 - 1981- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1975 - 1978
Yale School of MedicineClass of 1975
Harvard UniversityAB, Social Relations, Magna Cum Laude, Phi Beta Kappa, 1967 - 1971
Certifications & Licensure
OR State Medical License 1985 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Distinguished Service Award American College of Rheumatology, 2022
- Research Career Achievement Award Spondylitis Research and Treatment Network (SPARTAN), 2022
- Edward E Rosenbaum Endowed Professorship Oregon Health & Science University, 2001-2022
- Join now to see all
Clinical Trials
- A Clinical Trial of Infliximab for Uveitis Start of enrollment: 2001 Aug 01
- Rituximab in the Treatment of Scleritis and Non-Infectious Orbital Inflammation Start of enrollment: 2007 Jan 01
- Adalimumab (Humira) in the Treatment of Refractory Non-infectious Uveitis Start of enrollment: 2008 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- Scleritis and development of immune-mediated disease: A retrospective chart review.Gottman, M., Do, T., Ghetie, D., Morrison, T., Rosenbaum, J., Friedman, M.> ;The Journal of Rheumatology. 2024 Feb 1
- 1 citationsCharacterization of autoimmune eye disease in association with Down's syndrome.Amr M Zaki, Sirichai Pasadhika, Jerry C Huang, Akshay S Thomas, Bryn M Burkholder, Lyndell L Lim, Stephanie M Llop, Eric B Suhler, Grazyna Adamus, James T Rosenbaum> ;Eye. 2024 Feb 1
- 5 citationsManagement of Concomitant Inflammatory Bowel Disease or Uveitis in Patients with Psoriatic Arthritis: An Updated Review Informing the 2021 GRAPPA Treatment Recommendat...Jadon, D., Corp, N., van der Windt, D., Coates, L., Soriano, E., Kavanaugh, A., Raine, T., Rieder, F., Siebert, S., Zummer, M., Schwartzman, S., Rosenbaum, J., Michels...> ;The Journal of Rheumatology. 2023 Mar 1
- Join now to see all
Journal Articles
- Community Profiling of the Urinary Microbiota: Considerations for Low-Biomass SamplesRahel Nardos, James T Rosenbaum, Nature
Other
- The Microbiome and HLA-B27-Associated Acute Anterior UveitisJames Rosenbaum, MD, Nature
https://www.doximity.com/articles/d1bfcca6-0f9a-4396-941e-5ab321714e62
UpToDate, Wolters Kluwer Health - 2012-02-25 - The Microbiome and HLA-B27-Associated Acute Anterior UveitisJames Rosenbaum, MD, Nature
https://www.doximity.com/articles/d1bfcca6-0f9a-4396-941e-5ab321714e62
UpToDate, Wolters Kluwer Health - 2012-12-05
Press Mentions
James Rosenbaum Presented the Distinguished Service Award by the American College of RheumatologyNovember 14th, 2022- The Rising Toll of Autoimmune Diseases in Older PeopleAugust 10th, 2021
Managing Ocular Disorders in Inflammatory Joint Disease: An Interdisciplinary ApproachMarch 12th, 2019- Join now to see all
Grant Support
- Ophthalmology Core FacilityNational Eye Institute1995–2012
- Understanding Uveitis In A Multi-System Disease Model Of SpondyloarthropathyNational Eye Institute2011
- Gene Expression In Nonspecific Orbital Inflammatory DiseaseNational Eye Institute2011
- Endotoxin-Induced Uveitis RevisitedNational Eye Institute2009–2010
- Four Dimensional Imaging Of The Immune Response In VivoNational Eye Institute1999–2010
- Uveitis Gene-Expression ProfilingNational Eye Institute2005–2008
- Chemotactic Factors In Animal Models Of UveitisNational Eye Institute1986–2008
- Immunology/Molecular Biology Training In OphthalmologyNational Eye Institute1991–2007
- Uveitis Gene-Expressoin ProfilingNational Eye Institute2006
- "Remicade" In The Management Of Vision-Threatening UveitisNational Center For Research Resources2004–2005
- Anterior Uveal Dendritic CellsNational Eye Institute2001–2004
- Opthalmology Core FacilityNational Eye Institute2000–2004
- Four Dimentional Imaging Of The Immune Response In VivoNational Eye Institute2000–2003
- Chemotactic Factors In Models Of UveitisNational Eye Institute1994–2003
- Ophthalmology Core Facility SupplementNational Eye Institute2001
- Utility Of Intravenous Immunoglobulin In The Treatment Of UveitisNational Center For Research Resources1997–2001
- Endotoxin Induced UveitisNational Eye Institute1985–2000
- Core--Tissue CultureNational Eye Institute1997–1999
- Endotoxin-Induced UveitisNational Eye Institute1987–1996
- Growth Factors In Proliferative VitreoretinopathyNational Eye Institute1989–1992
Professional Memberships
- Master
Hospital Affiliations
Legacy Good Samaritan Medical CenterPortland, Oregon
OHSU HospitalPortland, Oregon
Industry Relationships
- Senior VP, Corvus Pharmaceuticals2022 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
